Corneal Edema
34
6
7
22
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 34 trials
100.0%
+13.5% vs benchmark
26%
9 trials in Phase 3/4
23%
5 of 22 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 22 completed trials
Clinical Trials (34)
Study of EO2002 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction
AURN001 Efficacy in Participants With Corneal Edema Secondary to Corneal Endothelial Dysfunction
Comparison of 5% Hypertonic Saline Versus 3% Hypertonic Saline in Resolution of Post-operative Corneal Edema.
Plasma Rich in Growth Factors in Corneal Endothelial Transplantation
EndoArt® Implantation in Subjects With Chronic Corneal Edema - US Study
Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery
PVEK Corneal Implant For Treatment of Corneal Edema
A Phase 1/2 Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1)
Study to Assess Safety and Tolerability of Multiple Doses of EO2002
The Belgian Endothelial Surgical Transplant of the Cornea
Validation of the Use of Terahertz Scanning System on Corneal Scars and Corneal Edema
Study of Safety and Tolerability of EO2002 in the Treatment of Corneal Edema
Study of Cryopreserved AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction
Air Optix® Night and Day® Aqua Therapeutic Wear
EndoArt® Implantation in Subjects With Chronic Corneal Edema
A Safety and Efficacy Study of Corneal Injection for Endothelial Dysfunction Using Human Corneal Endothelial Cell Therapy in Subjects With Corneal Edema Secondary to Endothelial Dysfunction
Loteprednol Etabonate 0.25% for Prevention of Cornea Transplant Rejection
Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Corneal Transplant Surgery
AONDA Therapeutic Indication Study I
A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy